Legal News

Evolving how English courts construe written commercial contracts (Teva v AstraZeneca)

Published on: 15 January 2018
Published by: LexisPSL
  • Evolving how English courts construe written commercial contracts (Teva v AstraZeneca)
  • Original news
  • What is the significance of this case?
  • What was the case about?
  • What was the decision?
  • How has the way in which English courts construe written commercial contracts changed?
  • What is the significance of the decision?
  • Could AstraZeneca have avoided the issue?
  • What are the practical implications of the judgment for practitioners?

Article summary

Dispute Resolution analysis: Matthew Warren, partner at Bristows LLP and head of the firm’s commercial IP group, advises that Teva v AstraZeneca reinforces the necessity for practitioners engaged in negotiating and drafting commercial contracts to achieve clarity, avoid ambiguity and to cover reasonably foreseeable potential future scenarios. or take a trial to read the full analysis.

Popular documents